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Introduction 
One of the rare but serious adverse reactions
to rifampicin therapy is thrombocytopenia
causing purpura. Nessi et al1 in their review of
allergic reactions during rifampicin treatment
described purpura either with normal platelet
count or with thrombocytopenia. Once rifampicin
is withheld, platelet count returns to normal.2,3,4,5
This rifampicin induced thrombocytopenia may
 be symptomless1,6 or lead to spontaneous
bruising.4 There is another group of purpura
namely, drug induced “allergic purpura”
characterised by aseptic vasculitis of vessels in
corium with normal or low platelet count.7
However, no case of cutaneous vasculitis with
purpura during rifampicin therapy has been
reported so far. We report two cases of purpura
with cutaneous vasculitis proved by skin biopsy in
two children who were on rifampicin therapy for
brain tuberculoma.
Case 1 : A ten year old girl, weighing 20 kg
came with left focal convulsions and was
diagnosed as a case of right parietal brain
tuberculoma based on CT Scan appearance. Her
initial platelet count was 2,80,000/cumm. She was
started on treatment with rifampicin 200 mg,
isoniazid 200 mg and pyrazinamide 500 mg on a
thrice weekly schedule, along with prednisolone 5
mg thrice daily and eptoin. During the sixth week
of therapy, she developed generalised joint pains
associated with knee, ankle, wrist, elbow swelling
and vomiting in association with generalised
abdominal pain. Within 24 hours of onset of joint
pains, purpuric spots developed in the upper and
lower extremities. Echymosis was observed in the
lower extremities over extensor aspect. A
haemogram showed total WBC count 13,000
cells/cumm, differential WBC count P 78%, L
19%, E 3%; PCV 44%, Hb. 13.4 gms, RBC count
3.4 million and platelets 2,50,000/cumm.
Peripheral blood smear was normocytic and
normochromic and showed no immature cells.
Bleeding time was 1 min 48 set and clotting time
was 5 min 5 sec. ESR was 21 mm at 1 hour. Urine
showed no albumin or RBCs. During the
following two days, she developed hematochezia,
hematuria and fresh purpuric spots in both the
extremities in the next five days. Sigmoidoscopy
done in view of hematochezia showed small
purpuric spots 7 cms from the anal orifice.
Rosewaaler test, ASO titre and LE cells, ANF
were negative. Platelet count after live days was
92,000/cumm. Biopsy of the purpuric lesion
showed vasculitis with fibrinoid deposits in some
areas of dermis and in vessel wall. Renal
functions were normal. A clinical diagnosis of
allergic purpura was made and all anti-
tuberculosis drugs were withheld. She was put on 
Prednisolone 30 mg along with antacids. Within a
week, she improved well. The platelet count came
up to 1,80,000/cumm. Rifampicin was terminated
and she was given Ethambutol and Isoniazid daily 
during which period she has remained free from
any adverse effect.
Case 2 : A six year old girl, weighing 25.5 kg
came with left focal convulsions and a CT scan
suggested right parietal brain tuberculoma. Pre-
treatment platelet count was 2,70,000/cumm. She 
was started on Rifampicin 200 mg, Isoniazid 200
mg, and Pyrazinamide 500 mg daily along with
Prednisolone 5 mg thrice daily and eptoin.
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Fig. 1. The presence of lymphocytes in the dermis; a
vessel wall infiltrated with mononuclear cells
(arrow) is also seen (Haematoxylin and eosin,
20 x 5).
Fig. 2. Higher power view of the dermal blood vessel
with mononuclear cell infiltration of its walls.
During the second week of therapy, she
developed purpuric rashes over the chest, trunk
and limbs. Her face appeared flushed and puffy.
During the next 48 hours, generalised rash was
observed. The investigations showed Hb. 10.2 gm,
WBC 9,900 cells/cumm, DC :-N 37%, L 57%, E
6%, platelet count 1,10,000/cumm, bleeding time
1 mn 35 sec, and clotting time 9 min 15 sec.
Biopsy of the rash revealed normal epidermis.
Dermis showed dilated blood vessels with
surrounding lymphocytic infiltration. There were
features of cutaneous vasculitis (Fig. 1). All drugs
were withheld. A week later, the platelet count
was 5,10,000/cumm. Three weeks later she was
started on Ethambutol and Isoniazid and she
completed the 12 months’ treatment period
without any untoward effects.
along with Phenytoin and steroids. During the
2nd week of therapy, she developed purpura.
Though thrombocytopenic purpura is described
with intermittent Rifampicin regimens,. this
patient presented with purpura on daily
Rifampicin.5
Discussion
Since the possibility of eptoin induced purpura
cannot be ruled out, eptoin was withheld in these
two cases and anti-convulsant was changed.
Whether Rifampicin and eptoin drug interaction
can precipitate such a reaction is also to be
considered. It- is surprising that these two cases
were also on steroids when they developed
purpura and one of the two cases needed higher
o es of steroids to control purpura. This may be
due to rapid metabolism of corticosteroids
resulting in lower serum levels of steroids, an
interaction of rifampicin on the basis of
microsomal enzyme induction in the liver.9
Allergic drug induced vasculitis has been
reported with drugs like sulfonamides, penicillin,
non-steroidal anti-inflammatory drugs, diphenyl-
hydantoin,etc.8 This presents clinically as
palpable purpura. Rifampicin, however, is known
to cause purpura due to thrombocytopenia.
In the two cases reported above, case 1 had
received Rifampicin, Isoniazid and Pyrazinamide
thrice weekly alongwith Phenytoin and steroids.
During the 6th week, the patient presented with
purpura when the platelet count was normal.
When the platelets count became low, the patient
developed systemic involvement in the form of
hematuria and rectal bleeding.
In both the cases, skin biopsy showed
lymphocytic infiltration of vessels in dermis. In
our Centre, Rifampicin is used in combination
with various other anti-tuberculosis drugs for
pulmonary and extra-pulmonary tuberculosis, like
tuberculous lymphadenitis, abdominal tuber-
culosis, spinal tuberculosis, etc. This is the first
time this complication of purpura with cutaneous
vasculitis has occurred in the Centre.
In conclusion, one should be wary of this
d eaded complication in a patient who receives
Rifampicin daily or intermittently along with
eptoin.
In case 2, the patient was on daily treatment
with Rifampicin, Isoniazid and Pyrazinamide
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